Rare diseases
Investigational molecules
Locations
Back to Italy2 209 clinical trials in Rome, Italy across 15 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Rilzabrutinib for Patients Aged 10-65 with Sickle Cell Disease
ItalyStudy on the Safety and Effectiveness of Atogepant for Preventing Chronic Migraine in Children Aged 12 to 17
ItalyStudy on the Safety and Effectiveness of NEU-411 for Patients with Early Parkinson's Disease
ItalyStudy Comparing Rinatabart Sesutecan with Other Treatments for Patients with Platinum-Resistant Ovarian Cancer
ItalyStudy of RLY-2608 for Adults and Children with PIK3CA-Related Overgrowth and Malformations
ItalyStudy of Tezepelumab Compared to Placebo in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
ItalyStudy of Relacorilant, Nab-Paclitaxel, and Bevacizumab for Patients with Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer
ItalyStudy of ENTR-601-45 Safety and Effectiveness in Patients with Duchenne Muscular Dystrophy Who Can Skip Exon 45
ItalyStudy on Long-term Safety of Zasocitinib for Adults with Moderate to Severe Ulcerative Colitis and Crohn's Disease
ItalyStudy of TAK-360 tablets to evaluate safety and effectiveness in people with Idiopathic Hypersomnia
ItalyStudy of Lisaftoclax combined with azacitidine for elderly patients with newly diagnosed acute myeloid leukemia
ItalyStudy on the Safety and Effectiveness of Emicizumab for Patients with Type 3 Von Willebrand Disease
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical studies focusing on Idiopathic Pulmonary Fibrosis and COPD, evaluating new therapeutic approaches for improving lung function and reducing disease progression.
Advanced research includes novel antibody treatments and preventive measures for respiratory infections.
Innovative trials targeting metastatic colorectal cancer, gastric cancer, and acute myeloid leukemia, exploring new treatment combinations and targeted therapies.
Studies focus on improving response rates and survival outcomes in various cancer types.
Research into Parkinson's disease and acute ischemic stroke, investigating novel therapeutic approaches and neuroprotective strategies.
Studies aim to improve neurological outcomes and patient quality of life.
Clinical trials examining Immune Thrombocytopenia and Hidradenitis Suppurativa, testing new therapeutic agents for immune-mediated conditions.
Research focuses on improving treatment outcomes in challenging immune disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
